18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results

Journal of Nuclear Medicine

Volumn 47, Issue 5, 2006, Pages 770-775

  De Geus Oei, Lioe Fee ^a   Pieters, Gerlach F F M ^a   Bonenkamp, Johannes J ^a   Mudde, Aart H ^b   Bleeker Rovers, Chantal P ^a   Corstens, Frans H M ^a   Oyen, Wim J G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLINGELAND HOSPITAL   (Netherlands)

Author keywords

18F FDG PET; Hemithyroidectomy; Inconclusive FNAB; Solitary thyroid nodules; Thyroid neoplasms

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTODIAGNOSIS; DIAGNOSTIC PROCEDURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID NODULE; THYROIDECTOMY; ALGORITHM; BIOPSY; CANCER INVASION; METABOLISM; METHODOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SCINTISCANNING; THYROID TUMOR;

ADULT; AGED; ALGORITHMS; BIOPSY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33745556546     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Singer PA, Cooper DS, Daniels GH, et al. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med. 1996;156:2165-2172.
2. Bloom AD, Adler LP, Shuck JM. Determination of malignancy of thyroid nodules with positron emission tomography. Surgery. 1993;114:728-734.
3. Hegedus L. Clinical practice: the thyroid nodule. N Engl J Med. 2004;351:1764-1771.
4. Rago T, Vitti P, Chiovato L, et al. Role of conventional ultrasonography and color flow-Doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol. 1998;138:41-46.
5. Kakkos SK, Scopa CD, Chalmoukis AK, et al. Relative risk of cancer in sonographically detected thyroid nodules with calcifications. J Clin Ultrasound. 2000;28:347-352.
6. Mikosch P, Gallowitsch HJ, Kresnik E, et al. Value of ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in an endemic goitre area. Eur J Nucl Med. 2000;27:62-69.
7. Kuma K, Matsuzuka F, Yokozawa T, Miyauchi A, Sugawara M. Fate of untreated benign thyroid nodules: results of long-term follow-up. World J Surg. 1994;18:495-498.
8. Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ. Ultrasound-guided fine-needle aspiration biopsy of thyroid masses. Thyroid. 1998;8:283-289.
9. Belfiore A, La Rosa GL. Fine-needle aspiration biopsy of the thyroid. Endocrinol Metab Clin North Am. 2001;30:361-400.
10. Utiger RD. The multiplicity of thyroid nodules and carcinomas. N Engl J Med. 2005;352:2376-2378.
11. Schoder H, Yeung HW. Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med. 2004;34:180-197.
12. Hooft L, Hoekstra OS, Boers M, Van Tulder MW, Van Diest P, Lips P. Practice, efficacy, and costs of thyroid nodule evaluation: a retrospective study in a Dutch university hospital. Thyroid. 2004;14:287-293.
13. Adler LP, Bloom AD. Positron emission tomography of thyroid masses. Thyroid. 1993;3:195-200.
14. Uematsu H, Sadato N, Ohtsubo T, et al. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med. 1998;39:453-459.
15. 18F]fluorodeoxyglucose positron emission tomography of the thyroid gland. Nucl Med Commun. 2003;24:1225-1230.
16. 18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy. Eur J Nucl Med. 1988;13:502-506.
17. Kresnik E, Gallowitsch HJ, Mikosch P, et al. Fluorine-18- fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery. 2003;133:294-299.
18. Sasaki M, Ichiya Y, Kuwabara Y, et al. An evaluation of FDG-PET in the detection and differentiation of thyroid tumours. Nucl Med Commun. 1997;18:957-963.
19. Hurtado-Lopez LM, Arellano-Montano S, Torres-Acosta EM, et al. Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging. 2004;31:1273-1279.
20. Demirel K, Kapucu O, Yucel C, Ozdemir H, Ayvaz G, Taneri F. A comparison of radionuclide thyroid angiography, (99m)Tc-MIBI scintigraphy and power Doppler ultrasonography in the differential diagnosis of solitary cold thyroid nodules. Eur J Nucl Med Mol Imaging. 2003;30:642-650.
21. Sharma R, Mondal A, Shankar LR, et al. Differentiation of malignant and benign solitary thyroid nodules using 30- and 120-minute Tc-99m MIBI scans. Clin Nucl Med. 2004;29:534-537.
22. 99mTc- SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. Eur J Endocrinol. 2003;149:493-498.
23. Vattimo A, Bertelli P, Cintorino M, et al. Hürthle cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy. J Nucl Med. 1998;39:822-825.
24. Alonso O, Lago G, Mut F, et al. Thyroid imaging with Tc-99m MIBI in patients with solitary cold single nodules on pertechnetate imaging. Clin Nucl Med. 1996;21:363-367.
25. Casara D, Rubello D, Saladini G. Role of scintigraphy with tumor-seeking agents in the diagnosis and preoperative staging of malignant thyroid nodules. Biomed Pharmacother. 2000;54:334-336.
26. Krak NC, Boellaard R, Hoekstra OS, Twisk JW, Hoekstra CJ, Lammertsma AA. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol Imaging. 2005;32:294-301.
27. Woolner LB, Beahrs OH, Black BM, McConahey WM, Keating FR Jr. Classification and prognosis of thyroid carcinoma: a study of 885 cases observed in a thirty year period. Am J Surg. 1961;102:354-387.
28. Sampson RJ, Woolner LB, Bahn RC, Kurland LT. Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer. 1974;34:2072-2076.
29. Harada T, Shimaoka K, Yakumaru K, Taniguchi T, Ito K. Prognosis of thyroid carcinoma. Int Adv Surg Oncol. 1981;4:83-110.
30. Cohen MS, Arslan N, Dehdashti F, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery. 2001;130:941-946.
31. 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab. 2003;88:4100-4104.
32. 18F- Fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope. 2005;115:1074-1078.